Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Redness, itching, or mild irritation at the application site can occur, particularly during initial use or with higher concentrations
The experiment was performed in three biological replicates
Key benefits Why people compare it 1 40-60% greater healing outcomes versus either peptide alone 2 Simultaneous activation of early-phase (TB-500) and mid-phase (BPC-157) repair 3 Synergistic upregulation of both VEGF/EGF and actin-migration pathways 4 Dual anti-inflammatory action: NO system modulation plus cytokine reduction 5 Single-vial reconstitution eliminates dosing variability 6 Optimized 1:1 mass ratio matching published combination protocols 7 Thorough tendon, ligament, muscle, and joint repair support 8 No emergent toxicity beyond individual component profiles Deep research About BPC-157 / TB-500 Blend This blend combines two structurally and mechanistically distinct peptides: BPC-157 (a 15-amino acid pentadecapeptide, MW ~1419 Da, sequence GEPPPGKPADDAGLV) and TB-500 (a synthetic 43-amino acid replica of Thymosin Beta-4, MW ~4921 Da)
Purity context: 99% listed purity
147 In a placebo-controlled crossover trial in men with coronary artery disease, 150 mg of DHEA per day for 40 days increased DHEA-S by 4.5-fold, increased estrogen (but not testosterone) levels, and lowered fibrinogen levels, but did not affect other measures of thrombosis risk
